Molecular and phenotypic analysis of Candida dubliniensis: A recently identified species linked with oral candidosis in HIV-infected and AIDS patients

Oral Diseases

Volumn 3, Issue SUPPL. 1, 1997, Pages

  Coleman, D ^a   Sullivan, D ^a   Harrington, B ^a   Haynes, K ^b   Henman, M ^a   Shanley, D ^a   Bennett, D ^a   Moran, G ^a   McCreary, C ^a   O'Neill, L ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Candida dubliniensis; Molecular epidemiology; Non albicans Candida species; Opportunistic pathogens; Oral candidosis; Oral yeast

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANDIDA; CANDIDA DUBLINIENSIS; CONFERENCE PAPER; DNA FINGERPRINTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; RIBOSOME SUBUNIT; THRUSH;

EID: 8244233846     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1997.tb00384.x     Document Type: Conference Paper

References (31)

1. Alsina AA, Mason M, Uphoff RA et al (1988). Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe. J Clin Microbiol 26: 621-624.
2. Anthony RM, Midgley J, Sweet SP et al (1995). Multiple strains of Candida albicans in the oral cavity of HIV positive and HIV negative patients. Microb Ecol Health Dis 8: 23-30.
3. Boerlin P, Boerlin-Petzold F, Durussel C et al (1995). Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users. J Clin Microbiol 33: 1129-1135.
4. Coleman DC, Bennett DE, Sullivan DJ et al (1993). Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol 19: 61-82.
5. Coleman DC, Bennett DE, Gallagher PJ et al (1995). Oral candidiasis and HIV infection; antifungal drug resistance and changes in Candida population dynamics. In: Greenspan JS, Greenspan D, eds. Oral manifestations of HIV infection. Quintessence Publishing Co., Inc: Chicago, pp 112-118.
6. Fell JW, Statzell-Tallman A, Lutz MR et al (1992). Partial rRNA sequences in marine yeasts; a model for identification of marine eukaryotes. Mol Mar Biol Biotechnol 1: 175-186.
7. Fell JW (1993). Rapid identification of yeast species using three primers in a polymerase chain reaction. Mol Mar Biol Biotechnol 3: 174-180.
8. Hazen C (1995). New and emerging yeast pathogens. Clin Microbiol Rev 8: 462-478.
9. Holmberg K, Meyer RD (1986). Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis 18: 179-192.
10. Johnson EM, Warnock DW, Lucker J et al (1995). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 35: 103-114.
11. Kamiyama A, Niimi M, Tokunaga M et al (1989). Adansonian study of Candida albicans: intraspecific homogeneity excepting C. stellatoidea strains. J Med Vet Mycol 27: 229-241.
12. Kwon-Chung KJ, Wickes BL, Merz WG (1988). Association of electrophoretic karyotype of Candida stellatoidea with virulence for mice. Infect Immun 56: 1814-1819.
13. Kwon-Chung KJ, Riggsby WS, Uphoff RA et al (1989). Genetic differences between type I and type II Candida stellatoidea. Infect Immun 57: 527-532.
14. Kwon-Chung KJ, Hicks JB, Lipke PN (1990). Evidence that Candida stellatoidea type II is a mutant of Candida albicans that does not express sucrose-inhibitable α-glucosidase. Infect Immun 58: 2804-2808.
15. Law D, Moore CB, Wardle HM (1994). High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 34: 659-668.
16. Le Guennec R, Reynes J, Mallié M et al (1995). Fluconazole-and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J Clin Microbiol 33: 2732-2737.
17. McCullough MJ, Ross BC, Dwyer BD et al (1994). The genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 140: 1195-1202.
18. McCullough MJ, Ross BC, Reade PC (1995). Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with the human immunodeficiency virus. J Clin Microbiol 33: 696-700.
19. Odds FC (1988). Candida and candidosis, 2nd edn. Baillière Tindall: London.
20. Odds FC, Bernaerts R (1994). CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32: 1923-1929.
21. Powderly WG (1992). Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 6: 604-605.
22. Rex JH, Rinaldi MG, Pfeller MA (1995). Resistance of Candida specieds to fluconazole. Antimicrob Agents Chemother 39: 1-8.
23. Ruhnke M, Eigler A, Engelmann E et al (1994). Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results of treatment with fluconazole. Infection 22: 132-136.
24. Sumaranayake LP (1992). Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 73: 171-180.
25. Scherer S, Stevens DA (1988). A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc Natl Acad Sci USA 85: 1452-1456.
26. Sullivan D, Bennett D, Henman M et al (1993). Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol 31: 2124-2133.
27. Sullivan DJ, Henman MC, Moran GP et al (1996). Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microbiol 44: 399-408.
28. Sullivan DJ, Westerneng TJ, Haynes KA et al (1995). Candida dubliniensis sp. nov: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141: 1507-1521.
29. Tavitian A, Raufman JP, Rosenthal LE (1986). Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Ann Intern Med 104: 54-55.
30. Wickes BL, Golin JE, Kwon-Chung KJ (1991). Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype. Infect Immun 59: 1762-1771.
31. Warnock D (1992). Azole drug resistance in Candida species. J Med Microbiol 37: 225-226.